BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3756845)

  • 1. Metabolism of tiazofurin by human erythrocytes and mononuclear blood cells in vitro.
    Roberts JD; Tong WP; Hartshorn JN; Hacker MP
    Cancer Lett; 1986 Aug; 32(2):193-7. PubMed ID: 3756845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective sensitivity to tiazofurin of human leukemic cells.
    Jayaram HN; Pillwein K; Nichols CR; Hoffman R; Weber G
    Biochem Pharmacol; 1986 Jun; 35(12):2029-32. PubMed ID: 3718544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).
    Green RM; Stewart DJ; Maroun JA
    Invest New Drugs; 1986; 4(4):387-94. PubMed ID: 3583646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tiazofurin in dogs.
    Obeng EK; Vallner JJ; Cadwallader DE; Tackett RL
    Biopharm Drug Dispos; 1987; 8(2):125-32. PubMed ID: 3593893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiazofurin metabolism in human lymphoblastoid cells: evidence for phosphorylation by adenosine kinase and 5'-nucleotidase.
    Fridland A; Connelly MC; Robbins TJ
    Cancer Res; 1986 Feb; 46(2):532-7. PubMed ID: 3000575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tiazofurin in the plasma and cerebrospinal fluid of rhesus monkeys.
    Grygiel JJ; Balis FM; Collins JM; Lester CM; Poplack DG
    Cancer Res; 1985 May; 45(5):2037-9. PubMed ID: 3986760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique bioactivation of tiazofurin--studies with resistant cells.
    Kuttan R
    Indian J Biochem Biophys; 1989 Jun; 26(3):160-5. PubMed ID: 2620910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiazofurin is phosphorylated by three enzymes from Chinese hamster ovary cells.
    Saunders PP; Spindler CD; Tan MT; Alvarez E; Robins RK
    Cancer Res; 1990 Sep; 50(17):5269-74. PubMed ID: 2143686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic K562 cells.
    Jayaram HN; Zhen W; Gharehbaghi K
    Cancer Res; 1993 May; 53(10 Suppl):2344-8. PubMed ID: 8097964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN; Ahluwalia GS; Jayaram HN; Cooney DA; Johns DG
    J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of resistance to tiazofurin in hepatoma 3924A.
    Jayaram HN; Pillwein K; Lui MS; Faderan MA; Weber G
    Biochem Pharmacol; 1986 Feb; 35(4):587-93. PubMed ID: 2868729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide--V. Factors governing the response of murine tumors to tiazofurin.
    Ahluwalia GS; Jayaram HN; Plowman JP; Cooney DA; Johns DG
    Biochem Pharmacol; 1984 Apr; 33(8):1195-203. PubMed ID: 6143562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disposition and metabolism of tiazofurin in rodents, rabbits, and dogs.
    Arnold ST; Jayaram HN; Harper GR; Litterst CL; Malspeis L; DeSouza JJ; Staubus AE; Ahluwalia GS; Wilson YA; Cooney DA
    Drug Metab Dispos; 1984; 12(2):165-73. PubMed ID: 6144481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I evaluation and pharmacokinetics of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).
    Melink TJ; Von Hoff DD; Kuhn JG; Hersh MR; Sternson LA; Patton TF; Siegler R; Boldt DH; Clark GM
    Cancer Res; 1985 Jun; 45(6):2859-65. PubMed ID: 3986813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism of ribavirin in erythrocytes and nucleated cells.
    Page T; Connor JD
    Int J Biochem; 1990; 22(4):379-83. PubMed ID: 2159925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of action of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). VI. Biochemical and pharmacological studies on the degradation of thiazole-4-carboxamide adenine dinucleotide (TAD).
    Ahluwalia GS; Cooney DA; Marquez VE; Jayaram HN; Johns DG
    Biochem Pharmacol; 1986 Nov; 35(21):3783-90. PubMed ID: 2877671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of tiazofurin in human colon carcinoma HT-29.
    Zhen W; Jayaram HN; Weber G
    Cancer Invest; 1992; 10(6):505-11. PubMed ID: 1358409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of thiazole-4-carboxamide adenine dinucleotide (TAD) levels in mononuclear cells of leukemic patients treated with tiazofurin.
    Zhen W; Jayaram HN; Weber G
    Biochem Pharmacol; 1991 Jan; 41(2):281-6. PubMed ID: 1989637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of nicotinamide adenine dinucleotide and poly(adenosine diphosphoribose) metabolism by the synthetic "C" nucleoside analogs, tiazofurin and selenazofurin. A new strategy for cancer chemotherapy.
    Berger NA; Berger SJ; Catino DM; Petzold SJ; Robins RK
    J Clin Invest; 1985 Feb; 75(2):702-9. PubMed ID: 3919063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of resistance to 6-aminonicotinamide.
    Saunders PP; Muhs MA; Arimilli S
    Anticancer Res; 1996; 16(2):843-8. PubMed ID: 8687139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.